clavulanic acid has been researched along with Respiratory Tract Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, Y; Kaniga, K; Livermore, DM; Mushtaq, S; Warner, M | 1 |
| Jedlicková, Z; Rubín, A; Simková, M; Výmola, F | 1 |
2 other study(ies) available for clavulanic acid and Respiratory Tract Diseases
| Article | Year |
|---|---|
In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
Topics: Acinetobacter; Anti-Bacterial Agents; Bacteria; Bacterial Proteins; Bacteroides; beta-Lactamases; Ceftaroline; Cephalosporins; Clavulanic Acid; Conjugation, Genetic; Drug Combinations; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Enterococcus; Escherichia coli; Gram-Negative Bacteria; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Phenotype; Respiratory Tract Diseases; Staphylococcus | 2007 |
Long-term experience with combined action of antibacterials.
Topics: Amoxicillin; Bacterial Infections; Bronchopneumonia; Child; Child, Preschool; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Humans; Respiratory Tract Diseases | 1986 |